Sym Financial Corporation »

Alnylam Pharmaceuticals shares owned by Sym Financial Corporation

Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by Sym Financial Corporation from 13F filings

Historical chart of Sym Financial Corporation investment in Alnylam Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals held by Sym Financial Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals by Sym Financial Corporation

Quarter filed Position value Share count Share price at filing
2024-12-31 $227k 963 235.31
2024-06-30 $217k 892 243.00

More positions owned by Sym Financial Corporation

Dimensional Etf Trust Intl Core Eqt Mk (DFAI)
Wisdomtree Tr Internationl Efi (NTSI)
Vanguard Index Fds Mcap Vl Idxvip (VOE)
Ishares Tr Us Treas Bd Etf (GOVT)
Vanguard Index Fds Total Stk Mkt (VTI)
Dow (DOW)
Schwab Strategic Tr Us Brd Mkt Etf (SCHB)
Ishares Tr Core Us Aggbd Et (AGG)
Vanguard Admiral Fds Smlcp 600 Val (VIOV)
Apple (AAPL)
Vanguard Star Fds Vg Tl Intl Stk F (VXUS)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Ishares Tr Core Msci Eafe (IEFA)
Amazon (AMZN)

View all positions for Sym Financial Corporation

Top funds holding Alnylam Pharmaceuticals

Capital World Investors
FMR
Vanguard Group
BlackRock
Capital Research Global Investors
Wellington Management Company
Baillie Gifford & Co
Capital Research and Management Company - Division 3
Dodge & Cox
State Street Corporation
T. Rowe Price Associates
T. Rowe Price Investment Management
Jpmorgan Chase & Co
Geode Capital Management
American Century Companies

View all funds holding Alnylam Pharmaceuticals